This document provides an overview of practical approaches to anemia. It discusses various causes of anemia including decreased or increased destruction of red blood cells. It classifies anemias based on mean corpuscular volume and provides case examples to demonstrate diagnostic approaches. Key learning points emphasize the importance of a rational diagnostic workup for anemia and identifying cases that need specialist attention. The document also cautions that transfusion is not always the only treatment for anemia.
This presentation is about anemia of chronic disease, nowadays also called as anemia of Inflammation. I have dealt with anemia in CKD and malignancy in detail.
This presentation is about anemia of chronic disease, nowadays also called as anemia of Inflammation. I have dealt with anemia in CKD and malignancy in detail.
causes of macrocytic anemia pathopysiology, sign and symptoms and the difference between macrocytic anemia megaloblastIc anemia. causes of hypersegmented neutrophils and its association between them. investigation and medical management plus pictures illustration.
Monocytes are the largest leukocytes in the circulation.
These are agranulocytes
Largest cells of normal blood
Body's second line of defense against infection
causes of macrocytic anemia pathopysiology, sign and symptoms and the difference between macrocytic anemia megaloblastIc anemia. causes of hypersegmented neutrophils and its association between them. investigation and medical management plus pictures illustration.
Monocytes are the largest leukocytes in the circulation.
These are agranulocytes
Largest cells of normal blood
Body's second line of defense against infection
Group project for Pathophysiology class on Anemia.
This presentation was a collaboration of Umbreen Bajwa, Jasmine Diaz, Vaittiare Ramirez , Lizth Romero, and Gerrie Rosario
p
r
r
1-Differentiate between the different causes of anemia
2. Discuss the investigations that may clarify the diagnosis
3. Recognize the predisposing factors and consequences of iron deficiency anemia and discuss how to manage it
4. Discuss the hereditary basis and clinical features of sickle cell anemia and thalassemia .
prepared by med_students0
case presentation on diagnosis of beta thalassemia majorDrShinyKajal
case history of 9 month old infant
Paediatric Clinical Approach to this case
examination
workup at blood centre
HPLC screening
laboratory findings
screening of father mother
prominent facial features
PBF and bone marrow findings
usg abdomen
xray skull
prbc transfusion therapy in thalassemia major
classification of thalassemia
national burden in india
pathogenesis- anemia skull bone iron overload
world thalassemia day
Interactive talk on common hematological and oncological emergencies - which if not noticed early can lead to irreversible complications and death .
Intended to be used for educational purposes for the fertile minds in medicine .
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
3. ‘It is often the physician and not the anemia
that is refractory’
4. Causes of anemia
Decreased production of RBCs
Aplastic anemia/pure red cell aplasia/
Myelodysplasia
Infiltration of marrow: malignancies (hematologic/
secondaries), fibrosis, granulomas
Nutritional deficiencies: iron, folate/B12
Increased destruction/ loss of RBCs
Hemolytic anemia
Hemorrhage
5. Iron deficiency
Thalassemia
Congenital
sideroblastic anemia
Lead poisoning
MICROCYTIC MACROCYTIC NORMOCYTIC
CLASSIFICATION BASED ON MCV
(Normal MCV: 80- 100 fl)
Megaloblastic anemia
MDS
Aplastic anemia
Hypothyroidism
Liver disease
Anemia chronic disease
Malignancies
Hemolytic anemias
6. Case
24 year lady 38 weeks pregnant
1st ANC visit: Hb 8 g WBC: 5000 Plt 4 lakhs
Physician consulted, advises IV iron sucrose,
1000 mg
Pt follows up late, 2nd trimester. Hb 8.5. Oral iron
and folate continued
3rd trimester: Hb 7.5g.
Hb electrophoresis done:Thal trait
7. Husband advised to undergo testing, refuses
as his Hb has always been 14g
Subsequently checks Hb electrophoresis:Thal
trait
8. Concept learnt
One must know when NOT to use iron
Look at MCV when checking hemogram
All ANC patients in the 1st ANC visit –
complete blood count must be checked (at
least by GPs if not the Gynecologist).
10. Case 2
30 year lady referred for refractory iron def anemia
2 years ago: Hb: 6g WBC: 5000 Plt: 4.5 lakhs
MCV 60, serum ferritin 2ng (15 -150)
Receives 3 units of blood, started on oral iron 1 tab
daily for 3 months.
Now presents with Hb 7 g
No menorrhagia, no bleeding history
Diagnosis?
Inadequate dose of iron
11. Concept to be revised
Dose of oral iron: 180 mg per day of elemental iron
Dose of IV iron: (14 – pt Hb) x body weight x 2.4 + 500
mg
Iron sucrose is available as 50 and 100 mg amp. Check
the strength and not number of ampoules
Unless appropriate dose if given and dietary advise
strictly given, patient will continue to have ‘refractory
anemia’
12. There is no role of IM iron (iron dextran) today.
Use oral iron whenever possible
Most side effects of oral iron (constipation) are
transient
Use iron sucrose if: non compliant patient,
intolerable side effects, malabsorption
Iron sucrose can be administered in your clinic,
no anaphylaxis known. Allergies may develop
DO NOT use > 200 mg at a time, administer over
an hour
16. Pica(pervertedeatinghabits)Latin
meaningbird
The habitual ingestion of unusual substances
earth, clay (geophagia)
laundry starch (amylophagia)
ice (pagophagia), tomatophagia
Usually is a manifestation of iron deficiency and
is relieved when the deficiency is treated
18. 71 yr male, k/c/o DM
Presented with weakness, fatigue, anorexia
Diagnosed to have Anemia since 2 yrs
Received adequate iron, B12, FA supplements
with some improvement
19. Hb- 6.1, TLC-12750, Plt- 463000
MCV- 68
PBS- MCHC, anisocytosis
Retic- 4.5, LDH- 400, Ferritin- 6.21
HAM, DCT- negative
Stool OB- Positive on two occasions
USG abdo, CXR- Normal
20. Upper GI scopy- normal
Colonoscopy- Two colonic pedunculated
polyps
HPE- Low grade dysplasia
21. Capsule Endoscopy- large ulcerative lesion in
ileum with active bleeding
CT abdomen-10 cm ileal wall thickening with
large ulcerative exophytic growth
22. Underwent resection anastomosis
HPE- Invasive adenocarcinoma with single
nodal metastasis (T3 N1 M0)
Now on chemo
23. 40 year male, symptomatic anemia since 3 months
Physical examination : normal
Hb: 5g% MCV: 110
TLC: 2800, N40 L50, M5, E5
Plt: 50,000
Retic: 1%
BM: Hypercellular, erythroid hyperplasia with
megaloblastic maturation, myeloids adequate with
megaloblastic changes, megakaryocytes seen
Impression: Megaloblastic anemia
24.
25. Diagnosis of megaloblastic
anemia
Macrocytic anemia with mild leucopenia and
thrombocytopenia
Knuckle pigmentation – prominent finding
PBS showing macro ovalocytosis,
hypersegmented neutrophils
High LDH
Bone marrow examination not required
27. Myelodysplastic
syndrome
Production of structurally and functionally
defective hemopoietic cells.
Peripheral blood cytopenia BM:
hypercellular with dysplastic changes.
May be impossible to distinguish
occasionally from megaloblastic anemia.
Treatment: BMT, lenalidomide/
thalidomide, erythropoietin.
28. 65 year lady presented with weakness,
lethargy
Clinically had just palpable spleen, no other
findings
Hb: 7 -9 g%, WBC: 2000 – 3000, Plt: 50 –
75,000
LDH normal, LFTs, RFTs normal
USG abdomen: mild splenomegaly
29. 1 hematologist starts treatment with
Lenalidomide (drug used to treat MDS)
Toxicity to Lenalidomide, pt sees another
hematologist who sees all reports, changes to
Thalidomide
Pt does not respond (blood counts remain
same)
Treatment changed to erythropoietin + G CSF
Good improvement noted in Hb and WBC
After 3 months spleen JP
30. Suddenly admitted with massive
hematemesis
UGI scopy done: Grade 4 varices
Dictum:
. Hypersplenism can occurWITHOUT
significant splenomegaly
31. Pancytopenia with splenomegaly – UGI scopy
indicated to rule out portal hypertension
Final diagnosis: Hypersplenism
32. Case
25 year man, admitted for malaria. PBS MP, optimal
negative. Has jaundice. DD: Leptospirosis
Treated for malaria 3 times in past by different
physicians. Also has had 2 episodes of jaundice in
past
Referred for mild anemia. Has splenomegaly 3 cm
Hb: 9g WBC: 6000 Plt 3 lakhs
MCV: 90
PBS reported normal
34. Learning lesson
Anemia with jaundice = hemolytic anemia if
the raised bilirubin is indirect, especially if
splenomegaly present
35. Transfusion in anemia
Patient hemodynamically unstable
Medications are not available to control
anemia
On going bleeding
36. Learning Points
Most anemias can be diagnosed by rational
approach.
Not all anemias are nutritional in original
Important to identify which anemia needs
specialist attention early
Transfusion is not the only answer to
treatment of anemia
39. Rheumatoid Arthritis:
Ulnar Deviation and MCP Swelling An across-the-room
diagnosis
Prominent ulnar
deviation in the right
hand
MCP and PIP swelling
in both hands
Synovitis of left wrist
40. RA: Anemia
• Clues of impending disaster
• High risk for NSAID gastropathy
• Presentation suggestive of blood loss
Pale, dizzy, weak
Tachycardia, low blood pressure
• No evidence of flare in RA to explain recent
symptoms of increased fatigue
42. Patient History
Acute or chronic
H/o Medication/Drug
G6PD
AIHA
Family history
Concomitant medical illnesses
Clinical presentation
43. Case
3 yr old male child presenting with
pallor,jaundice
Severe pain of long bones, fever
CBC-anemia,reticulocytosis,increased WBC
LAB - LDH -600 u/L (normal upto 200)
S.bilirubin- 5mg%
Unconjucated-3.6 mg %
45. CASE
6 yr old sindhi child presenting with severe
pallor,jaundice growth delay
“Chipmunk facies”,hepatosplenomegaly+
H/o recurrent blood transfusions
CBC-Hb -3gm%, MCV-58 fl(Nl-86-98),
-MCH- 19pg (nl-28-33)
46. CASE
45 yr old male came to OPD in a remote PHC
with burning micturation.
Urine R/M shows numerous pus cells.
UTI diagnosed & medical officer gave
Cotrimoxazole 2 bd X 5days
1 wk later,pt developed severe
pallor,palpitation,jaundice
Lab- increased LDH, S.BILIRUBIN,RETIC COUNT
P.B.S- shows bizarre poikilocytes.
56. 15 yr male
Hb: 12 g%
TLC: 4000
DLC: N40, L60
Plt: 15,000
15 yr male
Hb: 12 g%
TLC: 800
DLC: N10, L90
Plt: 2,00,000
57. Hb: 8g%, TLC: 800, Plt: 1,50,000
History- fever since 1 month, joint pains since
15 days, visited local GP, received injections
and tablets- fever and joint pains subsided
completely, patient now feels well